Vol 12: Combination treatment with oncolytic Vaccinia virus and cyclophosphamide results in synergistic antitumor effects in human lung adenocarcinoma bearing mice.Report as inadecuate



 Vol 12: Combination treatment with oncolytic Vaccinia virus and cyclophosphamide results in synergistic antitumor effects in human lung adenocarcinoma bearing mice.


Vol 12: Combination treatment with oncolytic Vaccinia virus and cyclophosphamide results in synergistic antitumor effects in human lung adenocarcinoma bearing mice. - Download this document for free, or read online. Document in PDF available to download.

Download or read this book online for free in PDF: Vol 12: Combination treatment with oncolytic Vaccinia virus and cyclophosphamide results in synergistic antitumor effects in human lung adenocarcinoma bearing mice.
This article is from Journal of Translational Medicine, volume 12.AbstractBackground: The capacity of the recombinant Vaccinia virus GLV-1h68 as a single agent to efficiently treat different human or canine cancers has been shown in several preclinical studies. Currently, its human safety and efficacy are investigated in phase I-II clinical trials.

Author: Hofmann, Elisabeth; Weibel, Stephanie; Szalay, Aladar A

Source: https://archive.org/







Related documents